Satellos Ev To Operating Cash Flow from 2010 to 2026

MSCL Stock   0.84  0.01  1.20%   
Satellos Bioscience EV To Operating Cash Flow yearly trend continues to be very stable with very little volatility. EV To Operating Cash Flow is likely to grow to 1.44 this year. EV To Operating Cash Flow is a valuation metric comparing Satellos Bioscience's enterprise value to its operating cash flow, indicating how many dollars of EV are generated for each dollar of operating cash flows. View All Fundamentals
 
EV To Operating Cash Flow  
First Reported
2010-12-31
Previous Quarter
1.37
Current Value
1.44
Quarterly Volatility
11.54972038
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Satellos Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Satellos Bioscience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 21.9 K, Selling General Administrative of 9.9 M or Selling And Marketing Expenses of 338.3 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.81. Satellos financial statements analysis is a perfect complement when working with Satellos Bioscience Valuation or Volatility modules.
  
This module can also supplement various Satellos Bioscience Technical models . Check out the analysis of Satellos Bioscience Correlation against competitors.

Latest Satellos Bioscience's Ev To Operating Cash Flow Growth Pattern

Below is the plot of the Ev To Operating Cash Flow of Satellos Bioscience over the last few years. It is a valuation metric comparing the company's enterprise value to its operating cash flow, indicating how many dollars of EV are generated for each dollar of operating cash flows. Satellos Bioscience's EV To Operating Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Satellos Bioscience's overall financial position and show how it may be relating to other accounts over time.
Ev To Operating Cash Flow10 Years Trend
Slightly volatile
   Ev To Operating Cash Flow   
       Timeline  

Satellos Ev To Operating Cash Flow Regression Statistics

Arithmetic Mean(14.92)
Coefficient Of Variation(77.43)
Mean Deviation10.65
Median(23.06)
Standard Deviation11.55
Sample Variance133.40
Range25.5075
R-Value0.84
Mean Square Error42.53
R-Squared0.70
Significance0.000028
Slope1.92
Total Sum of Squares2,134

Satellos Ev To Operating Cash Flow History

2026 1.44
2025 1.37
2023 1.52
2022 -1.04
2021 -3.82
2020 -23.99

About Satellos Bioscience Financial Statements

Satellos Bioscience investors utilize fundamental indicators, such as Ev To Operating Cash Flow, to predict how Satellos Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
EV To Operating Cash Flow 1.37  1.44 

Pair Trading with Satellos Bioscience

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Satellos Bioscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Satellos Bioscience will appreciate offsetting losses from the drop in the long position's value.

Moving against Satellos Stock

  0.58APS Aptose BiosciencesPairCorr
  0.55CM Canadian Imperial BankPairCorr
  0.47RY Royal BankPairCorr
  0.47AX-UN Artis Real EstatePairCorr
  0.44FTT Finning InternationalPairCorr
The ability to find closely correlated positions to Satellos Bioscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Satellos Bioscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Satellos Bioscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Satellos Bioscience to buy it.
The correlation of Satellos Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Satellos Bioscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Satellos Bioscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Satellos Bioscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Satellos Stock

Satellos Bioscience financial ratios help investors to determine whether Satellos Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Satellos with respect to the benefits of owning Satellos Bioscience security.